Viewing StudyNCT00113204



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00113204
Status: COMPLETED
Last Update Posted: 2008-05-20
First Post: 2005-06-06

Brief Title: Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Sponsor: Infinity Pharmaceuticals Inc
Organization: Infinity Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
plasma cells View
Multiple myeloma View
Relapsed View
Relapsed refractory View
Hematologic cancer View
hematologic disease View